Lakewood-Amedex Analyst Price Targets

Wall Street analyst price targets and consensus rating for Lakewood-Amedex (LABT).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$3Upside to Avg. PT+488.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 28, 2026	HC Wainwright & Co.	Matthew Keller	Initiate	Buy	$3

Analyst Ratings News

This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).

Avi Kapoor

This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.

Avi Kapoor

This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On Lakewood-Amedex with Buy Rating, Announces Price Target of $3

HC Wainwright & Co. analyst Matthew Keller initiates coverage on Lakewood-Amedex (NASDAQ:LABT) with a Buy rating and announces Price Target of $3.

Benzinga Newsdesk

PRO
Watching Lakewood-Amedex Biotherapeutics; Zacks Small-Cap Research Gives Stock $12 Price Valuation

Benzinga Newsdesk

Lakewood-Amedex Biotherapeutics Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Lakewood-Amedex Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
HC Wainwright & Co. Initiates Coverage On Lakewood-Amedex with Buy Rating, Announces Price Target of $3

PRO
Watching Lakewood-Amedex Biotherapeutics; Zacks Small-Cap Research Gives Stock $12 Price Valuation

People Also Watch

People Also Watch

Lakewood-Amedex Biotherapeutics Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Lakewood-Amedex Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROHC Wainwright & Co. Initiates Coverage On Lakewood-Amedex with Buy Rating, Announces Price Target of $3

PROWatching Lakewood-Amedex Biotherapeutics; Zacks Small-Cap Research Gives Stock $12 Price Valuation

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Initiates Coverage On Lakewood-Amedex with Buy Rating, Announces Price Target of $3

PRO
Watching Lakewood-Amedex Biotherapeutics; Zacks Small-Cap Research Gives Stock $12 Price Valuation